Medical Marijuana, Inc. v. ProjectCBD.com
Annotate this CasePlaintiffs Medical Marijuana, Inc. (MMI) and HempMeds PX, LLC (HempMeds) (jointly "the plaintiffs") sued defendants ProjectCBD.com (Project CBD), Martin Lee, and Aaron Cantu. Project CBD appealed a trial court's order denying their special motion to strike1 counts 1 and 3 of the complaint against them, which asserted causes of action for libel and false light. Plaintiff MMI held investments in numerous industrial hemp businesses, including plaintiff HempMeds. HempMeds manufactures and sells RSHO, a product containing cannabidiol (CBD) derived from the industrial hemp plant. MMI also holds interests in KannaLife Sciences, Inc. Per the first amended complaint, Jason Cranford, another defendant, resigned from KannaLife's Board of Directors and then began competing with MMI and HempMeds by selling CBD products through his Colorado medical marijuana dispensary, Rifle Mountain, LLC (Rifle Mountain - also named as a defendant in the case). Project CBD was a California nonprofit organization that identifies itself as an organization dedicated to promoting and publicizing research regarding CBD and other components of the cannabis plant. Project CBD had samples of plaintiffs’ cannabis product tested, and released results on their Facebook page. Plaintiffs contended that those results and other statements made about their products were false. On appeal, the Project CBD defendants contended that the trial court incorrectly determined that plaintiffs demonstrated a probability of prevailing on counts 1 and 3 against defendants. The Project CBD defendants also claimed that the trial court erred in concluding that plaintiffs were not limited public figures, meaning that the plaintiffs would not have to demonstrate that the Project CBD defendants acted with actual malice in publishing an article about the plaintiffs, and/or that the court erred in concluding in the alternative that the plaintiffs demonstrated that the Project CBD defendants acted with actual malice in publishing the article. The Court of Appeal concluded that the trial court's ruling with respect to the Project CBD defendants' anti-SLAPP motion directed at counts 1 and 3 was correct, albeit on grounds different from those relied on by the trial court. The Court therefore affirmed the trial court's order and remanded the matter for further proceedings.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.